Efficib Եվրոպական Միություն - անգլերեն - EMA (European Medicines Agency)

efficib

merck sharp and dohme b.v - sitagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - for patients with type-2 diabetes mellitus:efficib is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.efficib is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.efficib is indicated as triple combination therapy with a ppar agonist (i.e. a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a ppar agonist.efficib is also indicated as add on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dosage of insulin and metformin alone do not provide adequate glycaemic control.

Janumet Եվրոպական Միություն - անգլերեն - EMA (European Medicines Agency)

janumet

merck sharp & dohme b.v. - sitagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - for patients with type 2 diabetes mellitus:janumet is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.janumet is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.janumet is indicated as triple combination therapy with a ppar  agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a ppar  agonist.janumet is also indicated as add on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dosage of insulin and metformin alone do not provide adequate glycaemic control.

Sitagliptin/Metformin Galenicum 50 mg/850 mg film-coated tablets Մալթա - անգլերեն - Malta Medicines Authority

sitagliptin/metformin galenicum 50 mg/850 mg film-coated tablets

galenicum health, s.l. avenida diagonal 123, 11ª planta, 08005, barcelona, spain - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 milligram(s) ; metformin hydrochloride 850 milligram(s) - drugs used in diabetes

Sitagliptin/Metformin Galenicum 50 mg/1000 mg film-coated tablets Մալթա - անգլերեն - Malta Medicines Authority

sitagliptin/metformin galenicum 50 mg/1000 mg film-coated tablets

galenicum health, s.l. avenida diagonal 123, 11ª planta, 08005, barcelona, spain - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 milligram(s) ; metformin hydrochloride 1000 milligram(s) - drugs used in diabetes